Description
The Sovicell TRANSIL PPB Binding Kit estimates the binding of drugs to human serum albumin (HSA) and human alpha-1 glycoprotein (AGP/AAG) at a physiological ratio to predict plasma protein binding. Internal quality controls provide easy assessment of recovery, experiment and data quality.
Additional information
| Weight |
22.4 oz |
| Dimensions |
11.2 × 4.6 × 6.2 in |
| Unit Quantity |
96 well, 240 ul
|
| Shipping Temperature |
+4C
|
| Storage Temperature |
-20C
|
For research use only. not for diagnostic use.
Citations
Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies—In Vitro and In Vivo CharacterizationAuthors: Jakubiec M, et al.
ACS Chem Neurosci. 2024 May 14
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In VivoAuthors: Samuelsen, Ørjan, et al.
Antimicrobial Agents and Chemotherapy 64.6 (2020): e02415-19
Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In VitroAuthors: Lubelska, Annamaria, et al.
Molecules 24.24 (2019): 4472
Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid OligomersAuthors: Leithold, Leonie HE, et al.
Pharmaceutical research 33 (2016): 328-336
Towards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsAuthors: Chauhan, Jamal, et al.
PLoS One 11.10 (2016): e0164515
